
- ONCOLOGY Vol 13 No 12
- Volume 13
- Issue 12
Pain Medication Bill
Looks like Congress will pass a bill that makes it clear that physicians can prescribe pain medication for terminally ill patients, including those with cancer, without running afoul of the Drug Enforcement Administration (DEA). The DEA has charge of the
Looks like Congress will pass a bill that makes it clear that physicians can prescribe pain medication for terminally ill patients, including those with cancer, without running afoul of the Drug Enforcement Administration (DEA). The DEA has charge of the Controlled Substances Act (CSA), which says that physicians can prescribe narcotics only for legitimate medical purposes. Under current law, in a case where a patient dies in what appears to be an assisted suicide, the DEA can conduct an investigation and revoke the physicians CSA registration if he or she is found to have prescribed federally controlled substances as part of an assisted suicide, in 49 of 50 states. Often the State Medical Boards are the first to act in these situations.
The House and Senate bills (H.R. 2260/S. 1272) give physicians wide berth to use narcotics for the aggressive treatment of pain and suffering, even if the use of these drugs has the unintended effect of increasing the risk of death. In October, the House passed H.R. 2260, which has been endorsed by the American Medical Association (AMA). Yank Coble, MD, secretary-treasurer of the AMA, says the two bills provide a new and important statutory protection for physicians prescribing controlled substances for pain....
Articles in this issue
almost 26 years ago
Off-Label Drug Promotionalmost 26 years ago
Clinton Medical Records Privacy Proposalalmost 26 years ago
Call for Stronger Recommendations About Supplement Use During Chemotherapyalmost 26 years ago
Book Review:Pediatric Hematology, Second Editionalmost 26 years ago
Women Are Replacing Old Breast Implants With Newalmost 26 years ago
FTC Warns Against Home-Use Tests for HIVNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



















































































